Who makes Oral [14C] PF-07248144?

Oral [14C] PF-07248144 is developed by Pfizer Inc..

What development phase is Oral [14C] PF-07248144 in?

Oral [14C] PF-07248144 is FDA-approved (marketed).

What is the generic name of Oral [14C] PF-07248144?

oral-14c-pf-07248144 is the generic (nonproprietary) name of Oral [14C] PF-07248144.

Last reviewed 2026-04-20 · How we verify

Oral [14C] PF-07248144 (oral-14c-pf-07248144)

Pfizer Inc. · FDA-approved active Quality 2/100

At a glance

Generic name	oral-14c-pf-07248144
Sponsor	Pfizer Inc.
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oral [14C] PF-07248144 CI brief — competitive landscape report
Oral [14C] PF-07248144 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI